HIGHLIGHTS
- who: Yanni Wang from the Department of Pathology, Wuhan University, China have published the paper: Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers, in the Journal: (JOURNAL) of July/31,/2017
- what: The study was approved by the medical ethics committee of Peking University Cancer Hospital, and was conducted in accordance with the Declaration of Helsinki or comparable ethical standards . The authors investigated 51 GI cancer patients who received anti-PD-1/PDL1 monotherapy, and found a 47.1% incidence of irAEs, including 7.8% grade 3 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.